Search
Menu
Home
HTB
2018
March
HTB
March 2018
Contents
Editorial
30 March 2018: vol 19 no 6 – CROI 2018 part 2
14 March 2018: vol 19 no 5 – CROI 2018 part 1
Conference reports
CROI 2018: second reports
Ibalizumab 24-week phase 3 results and susceptibility to drug-resistant HIV
Statin use might reduce risk of cancer in HIV positive people
Rate of bone loss on ART slows after the first year
Standard dose of dolutegravir sufficient in late pregnancy: interim results from DolPHIN-1 study
Women’s risk of becoming HIV positive increases three-fold in late pregnancy and four-fold postpartum
Cure research at CROI 2018: defining and reducing the reservoir and the risks from interrupting treatment
25th Conference on Retroviruses and Opportunistic Infections (CROI 2018)
Inching towards an HIV cure: bNAb and TLR-7 agonist reduce viral rebound off-ART in macaques
No HIV evolution in plasma or lymph nodes on suppressive ART and no impact from further intensification
Dual therapy can reduce TB prophylaxis from nine months to one: fewer side effects and more people complete treatment
Twice-daily dolutegravir is effective and tolerable with rifampicin
Once-daily tenofovir alafenamide appears sufficient when dosed with rifampicin
Efavirenz 400 mg can be given with anti-tuberculosis treatment
Bictegravir at CROI 2018: switching studies and drug resistance analyses
PrEP at CROI 2018 (part 1): Access in Australia and the US
PrEP at CROI 2018 (part 2): Animal studies for future drugs
BHIVA best of CROI feedback workshops
Antiretrovirals
FDA approves ibalizumab in the US to treat multidrug HIV resistance
HIV prevention and transmission
Update on PrEP IMPACT study (March 2018)
Cure-related research
Elite controllers: sex differences and factors associated with loss of immune control
Assessing antiretroviral therapy interruptions in HIV cure research
Other news
US Congress rejects Trump’s proposed cuts to research budget for 2018
On the web
HCV advocacy training manual
PDFs
30 March 2018: vol 19 no 6
14 March 2018: vol 19 no 5
HTB RSS
Current issues
October 2024
September 2024
August 2024
Back issues
Special report
HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care
6 October 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage